STOCK PURCHASE AGREEMENTStock Purchase Agreement • May 10th, 2017 • Immunomedics Inc • In vitro & in vivo diagnostic substances • New York
Contract Type FiledMay 10th, 2017 Company Industry JurisdictionThis Stock Purchase Agreement (this “Agreement”) is dated as of February 10, 2017 (the “Effective Date”), by and between Immunomedics, Inc., a Delaware corporation (the “Company”), and Seattle Genetics, Inc., a Delaware corporation (together with any valid assignees of its rights hereunder pursuant to Section 5.6, the “Purchaser”).
STOCK PURCHASE AGREEMENTStock Purchase Agreement • May 1st, 2017 • Seattle Genetics Inc /Wa • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 1st, 2017 Company Industry JurisdictionThis Stock Purchase Agreement (this “Agreement”) is dated as of February 10, 2017 (the “Effective Date”), by and between Immunomedics, Inc., a Delaware corporation (the “Company”), and Seattle Genetics, Inc., a Delaware corporation (together with any valid assignees of its rights hereunder pursuant to Section 5.6, the “Purchaser”).
STOCK PURCHASE AGREEMENTStock Purchase Agreement • February 27th, 2015 • INSMED Inc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 27th, 2015 Company Industry JurisdictionThis Stock Purchase Agreement (this “Agreement”) is dated as of December 15, 2014 (the “Effective Date”), by and between Insmed Incorporated, a Virginia corporation (the “Company”), and Hercules Technology Growth Capital, Inc. (the “Purchaser”).